464 related articles for article (PubMed ID: 12584366)
1. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Marley JE; Morgan TO; West MJ;
N Engl J Med; 2003 Feb; 348(7):583-92. PubMed ID: 12584366
[TBL] [Abstract][Full Text] [Related]
2. Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia.
Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Marley JE; Morgan TO; Shaw J; Steven ID; West MJ
Clin Exp Hypertens; 1997; 19(5-6):779-91. PubMed ID: 9247755
[TBL] [Abstract][Full Text] [Related]
3. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
4. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
[TBL] [Abstract][Full Text] [Related]
6. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
7. Current recommendations for the treatment of hypertension: are they still valid?
Moser M
J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
[TBL] [Abstract][Full Text] [Related]
8. [The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].
Kolloch RE; Rahn KH
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):1-5. PubMed ID: 9465848
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.
Schneeweiss S; Walker AM; Glynn RJ; Maclure M; Dormuth C; Soumerai SB
N Engl J Med; 2002 Mar; 346(11):822-9. PubMed ID: 11893794
[TBL] [Abstract][Full Text] [Related]
11. Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial.
Yamal JM; Martinez J; Osani MC; Du XL; Simpson LM; Davis BR
JAMA Netw Open; 2023 Dec; 6(12):e2344998. PubMed ID: 38048133
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE
Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325
[TBL] [Abstract][Full Text] [Related]
13. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Niskanen L; Hedner T; Hansson L; Lanke J; Niklason A;
Diabetes Care; 2001 Dec; 24(12):2091-6. PubMed ID: 11723089
[TBL] [Abstract][Full Text] [Related]
14. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
Alderman MH; Madhavan S; Ooi WL; Cohen H; Sealey JE; Laragh JH
N Engl J Med; 1991 Apr; 324(16):1098-104. PubMed ID: 1759997
[TBL] [Abstract][Full Text] [Related]
15. A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker.
Dollar A; Brown C; Putnam D; McLaughlin T; Okamoto L; Arocho R
Clin Ther; 2002 Jun; 24(6):930-41. PubMed ID: 12117083
[TBL] [Abstract][Full Text] [Related]
16. Update on the management of hypertension: do recent clinical trial results indicate a change in national recommendations for therapy?
Moser M
J Clin Hypertens (Greenwich); 2002; 4(6 Suppl 2):20-31. PubMed ID: 12461317
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.
Lindholm LH; Hansson L; Ekbom T; Dahlöf B; Lanke J; Linjer E; Scherstén B; Wester PO; Hedner T; de Faire U
J Hypertens; 2000 Nov; 18(11):1671-5. PubMed ID: 11081782
[TBL] [Abstract][Full Text] [Related]
18. Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
Holmer SR; Hense HW; Danser AH; Mayer B; Riegger GA; Schunkert H
Heart; 1998 Jul; 80(1):45-8. PubMed ID: 9764058
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
[TBL] [Abstract][Full Text] [Related]
20. Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Chapman AB; Gabow PA; Schrier RW
Am J Nephrol; 2001; 21(2):98-103. PubMed ID: 11359016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
